Soleno Therapeutics
SLNO
#4421
Rank
A$3.84 B
Marketcap
A$73.83
Share price
0.00%
Change (1 day)
-30.94%
Change (1 year)

Earnings for Soleno Therapeutics (SLNO)

Earnings in 2026 (TTM): A$0.15 Billion

According to Soleno Therapeutics's latest financial reports the company's current earnings are A$0.28 Billion. In 2025 the company made an earning of A$36.72 Million, an increase over its 2024 earnings that were of -A$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soleno Therapeutics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.15 B323.31%
2025 A$36.72 M-115.52%
2024 -A$0.24 Billion339.22%
2023 -A$53.86 Million54.01%
2022 -A$34.98 Million-22.16%
2021 -A$44.94 Million0.97%
2020 -A$44.5 Million37.73%
2019 -A$32.31 Million96.94%
2018 -A$16.41 Million21.69%
2017 -A$13.49 Million-23.69%
2016 -A$17.67 Million-20.82%
2015 -A$22.32 Million86%
2014 -A$12 Million829.91%
2013 -A$1.29 Million